{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:13:11Z","timestamp":1790233991596,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/ki.2014.348","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T12:37:03Z","timestamp":1413981423000},"page":"749-760","source":"Crossref","is-referenced-by-count":43,"title":["Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans"],"prefix":"10.1016","volume":"87","author":[{"given":"Kozi","family":"Hosoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Minakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Futatsugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shinozuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Washida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirobumi","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.348_bb0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","article-title":"Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease","volume":"53","author":"Fliser","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.348_bb0015","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1210\/jcem.87.5.8453","article-title":"Altered temporal organization of plasma insulin oscillation in chronic renal failure","volume":"87","author":"Feneberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2014.348_bb0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.2004090742","article-title":"Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study","volume":"16","author":"Becker","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.348_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/clc.20901","article-title":"Insulin resistance, inflammation, and vascular disease in nondiabetic predialysis chronic kidney disease patients","volume":"34","author":"Banerjee","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1038\/ki.2014.348_bb0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone plasma lipoproteins, obesity and insulin resistance in Humans","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1038\/ki.2014.348_bb0035","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronesteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2014.348_bb0040","first-page":"F257","article-title":"Extrarenal potassium homeostasis","volume":"240","author":"Bia","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2014.348_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ki.1978.114","article-title":"Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure","volume":"14","author":"Berle","year":"1978","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.348_bb0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/10641968009037132","article-title":"Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension","volume":"2","author":"Reubi","year":"1980","journal-title":"Clin Exp Hypertens"},{"key":"10.1038\/ki.2014.348_bb0055","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.diabres.2008.09.024","article-title":"ADMA, cardiovascular disease and diabetes","volume":"82","author":"Krzyzanowska","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1038\/ki.2014.348_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000227819","article-title":"Asymmetric dimethylarginine impairs glucose utilization via ROS\/TLR4 pathway in adipocytes: an effect prevented by vitamin E","volume":"24","author":"Yang","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"10.1038\/ki.2014.348_bb0065","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/ki.2014.348_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3430209","article-title":"Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases","volume":"343","author":"Leiper","year":"1999","journal-title":"Biochem J"},{"key":"10.1038\/ki.2014.348_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1291\/hypres.28.181","article-title":"Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension","volume":"28","author":"Okubo","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1038\/ki.2014.348_bb0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1681\/ASN.2006040367","article-title":"Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease","volume":"18","author":"Tatematsu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.348_bb0085","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1096\/fj.12-226092","article-title":"DDAH2 enhances pancreatic insulin secretion in mice via transcriptional regulation of secretagogin through Sirt1-dependent mechanism","volume":"27","author":"Hasegawa","year":"2013","journal-title":"FASEB J"},{"key":"10.1038\/ki.2014.348_bb0090","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"St\u00fchlinger","year":"2002","journal-title":"JAMA"},{"key":"10.1038\/ki.2014.348_bb0095","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"10.1038\/ki.2014.348_bb0100","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2014.348_bb0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1038\/ki.2014.348_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsbmb.2006.10.006","article-title":"11-Beta hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity","volume":"104","author":"Milagro","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2014.348_bb0115","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.freeradbiomed.2010.06.029","article-title":"Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine","volume":"49","author":"Tain","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/ki.2014.348_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03498.x","article-title":"Role of aldosterone and angiotensin II in insulin resistance: an update","volume":"71","author":"Lastra-Lastra","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1038\/ki.2014.348_bb0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1751-7176.2010.00339.x","article-title":"Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome","volume":"12","author":"Costa","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1038\/ki.2014.348_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1038\/ki.2014.348_bb0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12224","article-title":"Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects","volume":"16","author":"Garg","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1038\/ki.2014.348_bb0140","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria","volume":"112","author":"Quinkler","year":"2005","journal-title":"Circulation"},{"key":"10.1038\/ki.2014.348_bb0145","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1097\/HJH.0b013e3283581a64","article-title":"Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease","volume":"30","author":"Naito","year":"2012","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2014.348_bb0150","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","article-title":"Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway","volume":"121","author":"Shibata","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.348_bb0155","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2215\/CJN.01340209","article-title":"Mineralocorticoid receptor blockers and chronic kidney disease","volume":"4","author":"Jain","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.348_bb0160","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2010.348","article-title":"Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet","volume":"78","author":"Wesson","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.348_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentrations in chronic renal disease","volume":"21","author":"Hen\u00e9","year":"1982","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.348_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ki.1973.115","article-title":"Studies on the metabolism of aldosterone on chronic renal failure and anephric man","volume":"4","author":"Williams","year":"1973","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.348_bb0175","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/diabetes.49.11.1751","article-title":"Triggering and amplifying pathways of regulation of insulin secretion by glucose","volume":"49","author":"Henquin","year":"2000","journal-title":"Diabetes"},{"key":"10.1038\/ki.2014.348_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.HYP.19.2_Suppl.II26","article-title":"Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy","volume":"19","author":"Plavinik","year":"1992","journal-title":"Hypertension"},{"key":"10.1038\/ki.2014.348_bb0185","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2014.348_bb0190","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2005-870240","article-title":"Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes","volume":"37","author":"Kraus","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1038\/ki.2014.348_bb0195","first-page":"554","article-title":"The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes","volume":"20","author":"Spoto","year":"2007","journal-title":"J Nephrol"},{"key":"10.1038\/ki.2014.348_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.108.121954","article-title":"Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation","volume":"53","author":"Wei","year":"2009","journal-title":"Hypertension"},{"key":"10.1038\/ki.2014.348_bb0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1038\/ki.2014.348_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2011.04.010","article-title":"Nitric oxide signaling: classical, less classical, and nonclassical mechanisms","volume":"51","author":"Mart\u00ednez-Ruiz","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/ki.2014.348_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2011.01.019","article-title":"Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress","volume":"216","author":"Doronzo","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1038\/ki.2014.348_bb0220","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.cellsig.2013.08.001","article-title":"Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells","volume":"25","author":"Mej\u00eda-Garc\u00eda","year":"2013","journal-title":"Cell Signal"},{"key":"10.1038\/ki.2014.348_bb0225","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1046\/j.1523-1755.1999.00458.x","article-title":"Effect of hyperinsulinemia on renal function in a general population: Hisayama Study","volume":"55","author":"Kubo","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.348_bb0230","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2014.348_bb0235","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MNH.0b013e32834b23c1","article-title":"Measurement of insulin resistance in chronic kidney disease","volume":"20","author":"Pham","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2014.348_bb0240","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2010.123","article-title":"Salt, aldosterone, and insulin resistance: impact on the cardiovascular system","volume":"7","author":"Lastra","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1038\/ki.2014.348_bb0245","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.diabres.2009.03.014","article-title":"Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model","volume":"84","author":"Tahara","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1038\/ki.2014.348_bb0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000287561","article-title":"Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease","volume":"31","author":"Freedman","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2014.348_bb0255","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2215\/CJN.11491210","article-title":"Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients","volume":"6","author":"Freedman","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.348_bb0260","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1038\/ki.2014.348_bb0265","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic US adults","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.348_bb0270","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.25.7.1177","article-title":"Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study","volume":"25","author":"Hanley","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2014.348_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1038\/ki.2014.348_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10157-006-0453-4","article-title":"Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease","volume":"11","author":"Imai","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2014.348_bb0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chroma.2008.05.034","article-title":"Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids","volume":"1200","author":"Yamashita","year":"2008","journal-title":"J Chromatogr"},{"key":"10.1038\/ki.2014.348_bb0290","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/01.CIR.89.5.2176","article-title":"Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine","volume":"89","author":"Tsao","year":"1994","journal-title":"Circulation"},{"key":"10.1038\/ki.2014.348_bb0295","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diab.37.6.707","article-title":"Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control","volume":"37","author":"Kaku","year":"1988","journal-title":"Diabetes"},{"key":"10.1038\/ki.2014.348_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI24335","article-title":"CCR2 modulates inflammatory and metabolic effects of high-fat feeding","volume":"116","author":"Weisberg","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.348_bb0305","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/01.ATV.0000219615.88323.b4","article-title":"Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells","volume":"26","author":"Hasegawa","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815302064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T02:47:40Z","timestamp":1554086860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815302064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0085253815302064"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.348","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}